Multibagger Stock on the auspicious occasion of Diwali 2015
Kopran, a pharma company, now in formulation business, is on buying mode, after company posted robust Q2 numbers, showing exemplary growth, QoQ.
QoQ, income rose to Rs. 80 crores, in Q2 from Rs. 63, growth of 27%. But OP rose by 100% to Rs. 6.33 crores from Rs. 3.14 crores. PAT rose by 364% to Rs. 2.83 crores, from Rs. 61 lakhs.
Debt of Rs. 80 crores, on consolidated basis, can get wiped off, when company will monetize its API unit at Mahad, for over Rs. 110 crores, which will be seen a positive trigger for stock going ahead.
expect share to touch Rs. 178/180 in next 2 Years cmp 63 SL-48